Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Erika Angelucci, Monica Cesarini, Piero Vernia

Open source

DOI
10.1007/s00296-009-1012-6
Published
2009-06-24
Container
Rheumatology International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00296-009-1012-6,
  title = {Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs},
  author = {Erika Angelucci and Monica Cesarini and Piero Vernia},
  year = {2009},
  journal = {Rheumatology International},
  doi = {10.1007/s00296-009-1012-6},
  url = {https://doi.org/10.1007/s00296-009-1012-6}
}

RIS

TY  - JOUR
TI  - Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs
AU  - Erika Angelucci
AU  - Monica Cesarini
AU  - Piero Vernia
PY  - 2009
JO  - Rheumatology International
DO  - 10.1007/s00296-009-1012-6
UR  - https://doi.org/10.1007/s00296-009-1012-6
ER  - 

APA

Angelucci, E., Cesarini, M., & Vernia, P. (2009). Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs. Rheumatology International. https://doi.org/10.1007/s00296-009-1012-6

Source records